AbbVie Biotech Ventures - also known as AbbVie Ventures - is a venture capital firm based in North Chicago, Illinois. The firm was founded in 2009, and it is a subsidiary of AbbVie. AbbVie itself was a business operation of Abbott Laboratories until 2013 when it became a separate company. As of October 2019, the firm has invested in 47 companies and maintains its ownership on 25 active companies.
Abbie Biotech Ventures focuses on investing in companies developing solutions in the fields of oncology, immunology, and neuroscience. The firm focuses on providing capital for eight companies each year. It prefers to invest in companies at the seed or series A stage.
Rheostat, located at 300 Technology Square, in Cambridge, Massachusetts is a biotech company developing treatments for neurodegenerative diseases by targeting mitophagy and autophagy pathways.
Rodeo Therapeutics is a preclinical-stage biotech company focused on first in class small molecule modulators of prostaglandin biology for enhancing tissue repair and regeneration.
Artios Pharma develops cancer treatments that target DNA Damage Response (DDR) Pathways to selectively kill cancer cells
Palleon Pharmaceuticals is a Waltham, Massachusetts-based company.